In 30 years, the survival rate of children with lymphoblastic leukemia has increased from 20% to almost 85%.
Research has allowed doctors to save the lives of children born prematurely who can weigh just 500g, and ensure their quality of life in the long term.
Before 1980, the majority of children with brain cancer died. Today, the majority survives and new treatments will soon be developed to improve their quality of life.
For 45 years, the median age of survival of children with cystic fibrosis has increased from 5 to 47 years.
In 20 years, the number of deaths from SIDS has dropped by more than half.
For 10 years, the assessment and treatment of children with viral bronchiolitis has greatly improved, reducing the risk of complications.
-10 years old survival rate for all childhood cancers: more than 75% until today
-In June 2016, a surgeon at the Montreal Children's Hospital saved the life of a newborn infant with Charge Disease, a complex syndrome that prevents the infant from swallowing normally with injections of Botox (botulinum toxin). It was the first time that such a young baby with Charge Syndrome was treated that way.
In 2010, Dr. Rouleau from CHU Ste-Justine was recognized internationally for her discovery of mutations in the genetic predisposition to autism and schizophrenia.
The team of researchers at the Montreal Children's Hospital has made a genetic breakthrough, recognized by “Actualité” news magazine as one of the 35 “game-changing” inventions: it is now possible to detect any genetic disease in record time with a powerful and reliable gene sequencing technique.
-In April 2016, a team of researchers at the Montreal Children's Hospital has demonstrated that certain abnormalities of vitamin B9, also called folic acid, are strongly implicated in the development of congenital heart defects.
-A study conducted by researchers at the Montreal Children's Hospital showed that high-dose ibuprofen could curb the development of cystic fibrosis and increase the life expectancy and quality of life of patients.